Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. Carducci MA, Padley RJ, Breul J, Vogelzang NJ, Zonnenberg BA, Daliani DD, Schulman CC, Nabulsi AA, Humerickhouse RA, Weinberg MA, Schmitt JL, Nelson JB, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD: J Clin Oncol 2003;21:679–689

Autor: Trump, Donald L
Zdroj: In Urologic Oncology: Seminars and Original Investigations 2003 21(5):410-411
Databáze: ScienceDirect
Externí odkaz: